If that's true, Patriot Scientific should have no problem officially stating it in public. One would think, in a time like this, the company would let shareholders know that we do in fact own 50%, as you say, of the reverse engineering data. As an investor I would find that news somewhat comforting. Also, I'm not sure how you could question someone regarding PDS expenditures. The passage below has been examined adnauseam. With that said, the company took action for a reason. Apparently they too, had concerns related to expenses being cross contaminated.

"On April 20, 2010 the Management Committee of PDS passed resolutions specifying that (i) any and all future licenses of the MMP Patent Portfolio must be approved in writing by a majority of the members of the Management Committee before they are agreed to or signed by TPL and (ii) effective immediately, TPL must not market patent portfolios in which PDS does not have an interest with the MMP Patent Portfolio. The TPL representative on the PDS Management Committee voted against the resolutions, and TPL has not expressed its acquiescence to the resolutions."